OMB Meeting Book - January 8, 2015

70

DRAFT, DO NOT DISTRIBUTE

S TAKEHOLDER P ANEL ON A GENT D ETECTION A SSAYS

February 3 – 4, 2015

AOAC INTERNATIONAL Headquarters 2275 Research Blvd., Rockville, Maryland, 20850

STAKEHOLDER PANEL AGENDA – FEBRUARY 3, 2014 (Day 1)

I.

Welcome and Introductions (9:00 a.m. – 9:15 a.m.) E. James Bradford, AOAC Executive Director

II.

Overview of Project (9:15 a.m. -9:35 a.m.) a. What, Why, and Timescales - Matthew Davenport, JHU/APL and SPADA Chair b. Review of Work Done - Matthew Davenport, JHU/APL and SPADA Chair

III.

Educational Overview of AOAC Standards Setting Processes (9:25 a.m. – 9:45 a.m.) Scott Coates, AOAC Chief Scientific Officer

IV.

Agreement on Concepts and Terminology (9:45 a.m. – 10:45 a.m.) Scott Coates, AOAC Chief Scientific Officer

V.

Working Group Launch Presentations a. Q Fever (11:00 a.m. – 12:00 p.m.) i. Overview & Challenges

ii. Agreement on Fitness for Purpose Statement (See Attachment 1 below)

---LUNCH---

b. Venezuelan Equine Encephalitis (VEE) (1:00 p.m. – 2:15 p.m.) i. Overview

ii. Agreement on Scope of Work / Fitness for Purpose Statement (Attachment 1) 1. PCR 2. Discussion: Development of a single or multiple SMPRs for a combination of VEE + Western Equine Encephalitis virus + Eastern Equine Encephalitis virus

c. Staphylococcus Enterotoxin B (SEB) (2:30 p.m. – 3:30 p.m.) i. Overview ii. Challenges

iii. Agreement on Fitness for Purpose Statement (Attachment 1) 1. Protein assay

3:45 – 4:45 p.m.: SPADA EXECUTIVE STEERING PANEL SESSION